Núria Chic

2.7k total citations · 1 hit paper
53 papers, 502 citations indexed

About

Núria Chic is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Núria Chic has authored 53 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 26 papers in Cancer Research. Recurrent topics in Núria Chic's work include Advanced Breast Cancer Therapies (33 papers), Breast Cancer Treatment Studies (19 papers) and HER2/EGFR in Cancer Research (16 papers). Núria Chic is often cited by papers focused on Advanced Breast Cancer Therapies (33 papers), Breast Cancer Treatment Studies (19 papers) and HER2/EGFR in Cancer Research (16 papers). Núria Chic collaborates with scholars based in Spain, United States and Italy. Núria Chic's co-authors include Aleix Prat, Fara Brasó‐Maristany, Olga Martínez‐Sáez, Eduardo Martínez de Dueñas, Tomás Pascual, Bárbara Adamo, María Vidal, Montserrat Muñoz-Mateu, Blanca González‐Farré and Francesco Schettini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Núria Chic

47 papers receiving 496 citations

Hit Papers

Frequency and spectrum of PIK3CA somatic mutations in bre... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Frequency and spectrum of PIK3CA somatic mutations in breast cancer
    2020 227 citations Olga Martínez‐Sáez, Núria Chic et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Núria Chic Spain 9 322 252 211 173 70 53 502
Fara Brasó‐Maristany Spain 10 474 1.5× 290 1.2× 284 1.3× 230 1.3× 79 1.1× 58 711
Manuel Ruíz Borrego Spain 12 369 1.1× 242 1.0× 166 0.8× 178 1.0× 78 1.1× 59 537
Sarah Croessmann United States 13 219 0.7× 136 0.5× 239 1.1× 217 1.3× 47 0.7× 26 492
Zhanfang Guo United States 11 335 1.0× 200 0.8× 154 0.7× 351 2.0× 63 0.9× 19 585
J-Y Pierga France 11 376 1.2× 135 0.5× 183 0.9× 113 0.7× 51 0.7× 53 479
Jorge E. Buendia-Buendia United States 5 238 0.7× 157 0.6× 186 0.9× 265 1.5× 23 0.3× 9 512
Utthara Nayar United States 6 193 0.6× 151 0.6× 98 0.5× 130 0.8× 39 0.6× 14 342
Leanne G. Ahronian United States 9 290 0.9× 174 0.7× 226 1.1× 198 1.1× 37 0.5× 18 524
Sun Min Lim South Korea 5 359 1.1× 291 1.2× 108 0.5× 153 0.9× 41 0.6× 8 497
Lisa Flaum United States 11 370 1.1× 207 0.8× 299 1.4× 127 0.7× 20 0.3× 32 535

Countries citing papers authored by Núria Chic

Since Specialization
Citations

This map shows the geographic impact of Núria Chic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Chic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Chic more than expected).

Fields of papers citing papers by Núria Chic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Chic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Chic. The network helps show where Núria Chic may publish in the future.

Co-authorship network of co-authors of Núria Chic

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Chic. A scholar is included among the top collaborators of Núria Chic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Chic. Núria Chic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanfeliu, Esther, Elia Seguí, Raquel Gómez Bravo, et al.. (2024). Abstract PO2-01-13: Clinico-Pathological and Molecular Characterization of Early Hormone Receptor-Positive Breast Cancer in Young Women. Cancer Research. 84(9_Supplement). PO2–1. 1 indexed citations
2.
Martínez‐Sáez, Olga, Francesco Schettini, César Sánchez, et al.. (2024). Hormone receptor-positive early breast cancer in young women: A comprehensive review. Cancer Treatment Reviews. 129. 102804–102804. 4 indexed citations
3.
Fernández-Martínez, Aranzazu, Tomás Pascual, Baljit Singh, et al.. (2023). Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA Oncology. 9(4). 490–490. 36 indexed citations
4.
Schettini, Francesco, Olga Martínez‐Sáez, Claudette Falato, et al.. (2023). Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis. ESMO Open. 8(3). 101214–101214. 8 indexed citations
5.
Martínez‐Sáez, Olga, Fara Brasó‐Maristany, Mercedes Marín‐Aguilera, et al.. (2023). 8P First decision impact study of HER2DX in patients (pts) with HER2-positive (HER2+) early breast cancer. ESMO Open. 8(1). 101232–101232.
6.
Rodríguez, A., Olga Martínez‐Sáez, Fara Brasó‐Maristany, et al.. (2022). 263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET). Annals of Oncology. 33. S657–S658. 2 indexed citations
7.
8.
Buus, Richard, Zsolt Szíjgyártó, Eugene F. Schuster, et al.. (2021). Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®. npj Breast Cancer. 7(1). 15–15. 9 indexed citations
9.
Chic, Núria, Fara Brasó‐Maristany, & Aleix Prat. (2021). Biomarkers of immunotherapy response in breast cancer beyond PD-L1. Breast Cancer Research and Treatment. 191(1). 39–49. 13 indexed citations
10.
Chic, Núria, Stephen J. Luen, Paolo Nucíforo, et al.. (2021). Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer. JNCI Journal of the National Cancer Institute. 114(3). 467–470. 10 indexed citations
11.
Fernández-Martínez, Aranzazu, Tomás Pascual, Baljit Singh, et al.. (2021). 120MO Prognostic value of immune gene-expression signatures (iGES) vs tumor-infiltrating lymphocytes (TILs) in early-stage HER2+ breast cancer: A combined analysis of CALGB 40601 (C40601) and PAMELA trials. Annals of Oncology. 32. S409–S409. 2 indexed citations
12.
Chic, Núria, Laura Mezquita, Mihaela Aldea, et al.. (2020). Successful Switch to Vemurafenib Plus Cobimetinib After Dabrafenib Plus Trametinib Toxicity in BRAFV600E-Mutant Metastatic Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 22(1). e54–e56. 5 indexed citations
13.
Martínez‐Sáez, Olga, Tomás Pascual, Fara Brasó‐Maristany, et al.. (2020). 5P Circulating tumour DNA (ctDNA) dynamics using a standardized multi-gene panel in advanced breast cancer patients (pts) treated with CDK4/6 inhibitors (CDK4/6i). Annals of Oncology. 31. S17–S17.
14.
González‐Farré, Blanca, Paolo Nucíforo, Javier Cortés, et al.. (2020). 15P The CelTIL score as an early predictor of anti-tumour response following neoadjuvant therapy (NAT): A SOLTI biomarker analysis. Annals of Oncology. 31. S22–S22.
15.
Griguolo, Gaia, Garazi Serna, Tomás Pascual, et al.. (2020). 8P Characterization of immune microenvironment before and following anti-HER2 neoadjuvant therapy (NAT). Annals of Oncology. 31. S19–S19. 1 indexed citations
16.
Guarneri, Valentina, Maria Vittoria Dieci, Giancarlo Bisagni, et al.. (2020). 19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study. Annals of Oncology. 31. S23–S23. 3 indexed citations
17.
Schettini, Francesco, Núria Chic, Fara Brasó‐Maristany, et al.. (2020). 23P Clinical, pathological and gene expression features of HER2-low breast cancer. Annals of Oncology. 31. S24–S24. 1 indexed citations
18.
Adamo, Bárbara, Lorena Moreno, Lydia Gaba, et al.. (2019). Multi-gene panel testing at the hereditary breast and ovarian cancer (HBOC) unit of the Hospital Clinic of Barcelona. Annals of Oncology. 30. iii42–iii43.
19.
Griguolo, Gaia, Fara Brasó‐Maristany, Tomás Pascual, et al.. (2019). ERBB2 mRNA as predictor of response to anti-HER2 antibody-drug conjugates (ADC) in breast cancer (BC). Annals of Oncology. 30. iii7–iii7. 4 indexed citations
20.
Cejalvo, Juan Miguel, Tomás Pascual, Aranzazu Fernández-Martínez, et al.. (2017). Distribution of the PAM50 breast cancer subtypes within each pathology-based group: a combined analysis of 15,339 patients across 29 studies. Annals of Oncology. 28. v603–v603. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fara Brasó‐Maristany Breakdown of academic impact, for papers by Manuel Ruíz Borrego Breakdown of academic impact, for papers by Sarah Croessmann Breakdown of academic impact, for papers by Zhanfang Guo Breakdown of academic impact, for papers by J-Y Pierga Breakdown of academic impact, for papers by Jorge E. Buendia-Buendia Breakdown of academic impact, for papers by Utthara Nayar Breakdown of academic impact, for papers by Leanne G. Ahronian Breakdown of academic impact, for papers by Sun Min Lim Breakdown of academic impact, for papers by Lisa Flaum
Rankless by CCL
2026